0001235802-22-000111.txt : 20220915
0001235802-22-000111.hdr.sgml : 20220915
20220915164128
ACCESSION NUMBER: 0001235802-22-000111
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220913
FILED AS OF DATE: 20220915
DATE AS OF CHANGE: 20220915
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daves Julie VanOrsdel
CENTRAL INDEX KEY: 0001945603
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36291
FILM NUMBER: 221246196
MAIL ADDRESS:
STREET 1: 301 CARLSON PARKWAY, SUITE 210
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DiaMedica Therapeutics Inc.
CENTRAL INDEX KEY: 0001401040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: Z4
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: TWO CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
BUSINESS PHONE: (763) 496-5454
MAIL ADDRESS:
STREET 1: TWO CARLSON PARKWAY
STREET 2: SUITE 260
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55447
FORMER COMPANY:
FORMER CONFORMED NAME: DiaMedica Inc.
DATE OF NAME CHANGE: 20070525
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-09-13
0
0001401040
DiaMedica Therapeutics Inc.
DMAC
0001945603
Daves Julie VanOrsdel
301 CARLSON PARKWAY, SUITE 210
MINNEAPOLIS
MN
55305
0
1
0
0
SVP Clinical Development Oper.
Voting Common Shares, no par value per share
0
D
Stock Option (right to buy)
1.47
2022-09-13
4
A
0
140000
0
A
2032-09-12
Common Shares
140000
140000
D
This option vests with respect to 35,000 common shares on September 13, 2023 and with respect to the remaining 75% of the common shares in 36 nearly equal monthly installments commencing one month after the one-year anniversary of the grant date.
/s/ Amy Culbert, attorney-in-fact
2022-09-15